Are you sure Bedger ? at least IMHO OPT discussion at HC is well balanced and high IQ in the most part , infact I would say most discussion is pretty positive.
OPT from my perspective offers one of the best risk reward cases I have evaluated.
Ann: Opthea to Present at Clinical Trials at the Summit Meeting, page-3
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $398.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.8¢ | 36.0¢ | $480.8K | 1.298M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34921 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 14866 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |